Anna Chatzidaki is an experienced professional in the pharmaceutical sector, currently serving as the Director of New Products Strategy & Innovation at Ipsen since May 2022. Prior to this role, Anna held positions at EY as a Senior Manager, Guidehouse as a Managing Consultant, and Navigant, where Anna also served as a Managing Consultant and Senior Consultant. Anna's earlier career includes consultancy roles at Deallus Consulting and MRC CASE placement at Eli Lilly and Company. Anna began a career in the industry with an Industrial Trainee position at Pfizer and a Biomedical vacation undergraduate project at Wellcome Trust. Anna Chatzidaki earned a PhD in Molecular Pharmacology from UCL and a BSc in Pharmacology from The University of Edinburgh.
This person is not in any teams
This person is not in any offices